Vimarsana
Biggest News Aggregation in the World

Page 27 - Cardiovascular Sciences News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Cardiovascular Sciences. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Cardiovascular Sciences Today - Breaking & Trending Today

Severe fatty liver disease could be treated with new drug - 'significant' discovery - Vimarsana News

Severe fatty liver disease could be treated with new drug - 'significant' discovery

Millions of people worldwide could benefit from the drug that can potentially treat a severe form of fatty liver disease.

VUMC-Led Trial Shows 2-Investigational Drugs Ineffective for Treating Severe COVID-19 - Vimarsana News

VUMC-Led Trial Shows 2-Investigational Drugs Ineffective for Treating Severe COVID-19

Health News - Despite the success of vaccines for preventing COVID-19, and of drugs for treating the disease, outcomes for severely ill patients admitted to the hospital remains poor. Identifying new therapies for severe COVID-19 remains a high priority and one in which Vanderbilt University Medical Center is taking a leading role. A study published April 11 in the Journal of the American Medical Association (JAMA) evaluated two drugs that act on the renin-angiotensin system (RAS ...

Potential drug DT-109 brings hope for human fatty liver treatment - Vimarsana News

Potential drug DT-109 brings hope for human fatty liver treatment

Washington, Apr 11 (Prensa Latina) A recently developed amino acid compound successfully treats nonalcoholic fatty liver disease in non-human primates — bringing scientists one step closer to the first human treatment for the condition that is rapidly increasing around the world, a study suggests.

Potential Drug Treats Fatty Liver Disease in Animal Models - Vimarsana News

Potential Drug Treats Fatty Liver Disease in Animal Models

Nonalcoholic steatohepatitis, or NASH, is a severe liver disease and impacts millions of people

Novel amino acid compound treats nonalcoholic fatty liver disease in non-human primates - Vimarsana News

Novel amino acid compound treats nonalcoholic fatty liver disease in non-human primates

A recently developed amino acid compound successfully treats nonalcoholic fatty liver disease in non-human primates -; bringing scientists one step closer to the first human treatment for the condition that is rapidly increasing around the world, a study suggests.